Skip to main content

Table 4 Prevalence of metabolic syndrome according to different criteria used

From: Increased frequency of metabolic syndrome among Vietnamese women with early rheumatoid arthritis: a cross-sectional study

 

n

JC 2009

IDF 2005

NCEP 2004

NCEP 2001

EGIR 1999

WHO 1998

Total

       

RA

105

34 (32.4)†‡

43 (40.9)†‡

34 (32.4)†‡

26 (24.7)†‡

17 (16.2)†‡

20 (19.0†‡

Controls

105

19 (18.1)

24 (22.9)

19 (18.1)

15 (14.2)

11 (10.5)

13 (12.4)

20 to 39 years

       

RA

19

5 (26.3)†

7 (36.8)†

5 (26.3)†

2 (10.6)†

1 (5.3)†

1 (5.3)†

Controls

19

2 (10.6)

3 (15.8)

2 (10.6)

1 (5.3)

0 (0)

0 (0)

40 to 59 years

       

RA

51

16 (31.4)†

21 (41.2)†

16 (31.4)†

13 (25.5)†

8 (15.7)†

10 (19.6)†

Controls

51

8 (15.7)

10 (19.6)

8 (15.7)

7 (13.7)

5 (9.8)

6 (11.8)

≥60 years

       

RA

35

13 (37.1)†

17 (48.6)†

13 (37.1)†

11 (31.4)†

8 (22.9)†

9 (25.7)†

Controls

35

9 (25.7)

11 (31.4)

9 (25.7)

7 (20.0)

6 (17.1)

7 (20.0)

  1. Values are the number (%); EGIR, European Group for Study of Insulin Resistance; IDF, International Diabetes Federation; JC, Joint Consensus; NCEP/ATP, National Cholesterol Education Program Adult Treatment Panel; RA, rheumatoid arthritis; WHO, World Health Organization. †: p < 0.001 for comparison between RA patients and healthy controls; ‡: p < 0.001 for comparison between different age groups in RA patients and healthy controls.